Trials will have very strict parameters and testing is limited within these. Nice parallel thinking though.
As an antiviral it should have other applications, but these will need to be tested separately. Logically, you would need a cohort suffering from another ailment for the testing to be valid.
- Forums
- ASX - By Stock
- BIT
- $30 Billion Deal
$30 Billion Deal, page-4517
-
- There are more pages in this discussion • 563 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.4¢ |
Change
0.001(3.03%) |
Mkt cap ! $30.67M |
Open | High | Low | Value | Volume |
3.4¢ | 3.4¢ | 3.3¢ | $632 | 18.85K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 287617 | 3.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 37989 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 287617 | 0.033 |
3 | 215000 | 0.032 |
2 | 332500 | 0.031 |
8 | 540666 | 0.030 |
1 | 100000 | 0.029 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 10000 | 1 |
0.036 | 65500 | 1 |
0.037 | 537816 | 2 |
0.039 | 490546 | 3 |
0.040 | 113240 | 2 |
Last trade - 13.36pm 19/07/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |